The Medical journal of Australia
-
To assess progress in Australia toward the 2030 WHO hepatitis C elimination targets two years after the introduction of highly effective direct-acting antiviral (DAA) treatments. ⋯ Hepatitis C elimination programs in Australia should focus on increasing testing rates and linkage with care to maintain adequate levels of treatment.
-
Observational Study
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
To assess the efficacy of corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). ⋯ Corticosteroids are widely used when treating patients with COVID-19, but we found no association between therapy and outcomes in patients without acute respiratory distress syndrome. An existing HBV infection may delay SARS-CoV-2 clearance, and this association should be further investigated.